Analystreport

Takeda Pharmaceutical Co Ltd (NYSE: TAK) was downgraded by analysts at Daiwa Capital Markets from an "outperform" rating to a "neutral" rating.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK)